Operating Lease, Liability, Noncurrent of Enliven Therapeutics, Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary: Enliven Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2021 to 30 Sep 2025.
Enliven Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 30 Sep 2025 was $103,000.
Source SEC data: View on sec.gov

Operating Lease, Liability, Noncurrent, Quarterly (USD)

Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Enliven Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$103,000	+$103,000		30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q2 2025	$204,000	+$204,000		30 Jun 2025	10-Q	13 Aug 2025	2025	Q2
Q1 2025	$302,000	+$302,000		31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q3 2024	$0	-$81,000	-100%	30 Sep 2024	10-Q	13 Nov 2024	2024	Q3
Q2 2024	$0	-$162,000	-100%	30 Jun 2024	10-Q	13 Aug 2024	2024	Q2
Q1 2024	$0	-$242,000	-100%	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$0	-$321,000	-100%	31 Dec 2023	10-K	14 Mar 2024	2023	FY
Q3 2023	$81,000			30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$162,000			30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$242,000	-$1,725,000	-88%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$321,000	-$85,000	-21%	31 Dec 2022	8-K	23 Jun 2023
Q1 2022	$1,967,000	+$1,377,000	+233%	31 Mar 2022	10-Q	06 May 2022	2022	Q1
Q4 2021	$406,000			31 Dec 2021	10-K	10 Feb 2023	2022	FY
Q3 2021	$466,000			30 Sep 2021	10-Q	09 Nov 2021	2021	Q3
Q2 2021	$528,000			30 Jun 2021	10-Q	06 Aug 2021	2021	Q2
Q1 2021	$590,000			31 Mar 2021	10-Q	11 May 2021	2021	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.